- Home
- NVCT vs PHD Comparison
NVCT vs PHD Comparison
Compare NVCT & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- PHD
- Stock Information
- Founded
- NVCT 2020
- PHD 2004
- Country
- NVCT United States
- PHD United States
- Employees
- NVCT N/A
- PHD N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- PHD Investment Managers
- Sector
- NVCT Health Care
- PHD Finance
- Exchange
- NVCT Nasdaq
- PHD Nasdaq
- Market Cap
- NVCT 130.6M
- PHD 121.9M
- IPO Year
- NVCT 2022
- PHD N/A
- Fundamental
- Price
- NVCT $7.59
- PHD $9.65
- Analyst Decision
- NVCT Strong Buy
- PHD
- Analyst Count
- NVCT 1
- PHD 0
- Target Price
- NVCT $21.00
- PHD N/A
- AVG Volume (30 Days)
- NVCT 133.8K
- PHD 67.7K
- Earning Date
- NVCT 03-04-2025
- PHD 01-01-0001
- Dividend Yield
- NVCT N/A
- PHD 11.43%
- EPS Growth
- NVCT N/A
- PHD N/A
- EPS
- NVCT N/A
- PHD 1.27
- Revenue
- NVCT N/A
- PHD N/A
- Revenue This Year
- NVCT N/A
- PHD N/A
- Revenue Next Year
- NVCT N/A
- PHD N/A
- P/E Ratio
- NVCT N/A
- PHD $7.60
- Revenue Growth
- NVCT N/A
- PHD N/A
- 52 Week Low
- NVCT $4.44
- PHD $8.30
- 52 Week High
- NVCT $12.10
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- NVCT 62.94
- PHD 43.20
- Support Level
- NVCT $7.38
- PHD $9.66
- Resistance Level
- NVCT $8.13
- PHD $9.75
- Average True Range (ATR)
- NVCT 0.66
- PHD 0.05
- MACD
- NVCT 0.05
- PHD 0.00
- Stochastic Oscillator
- NVCT 76.72
- PHD 5.26
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.